Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeoImmuneTech Inc.

www.neoimmunetech.com

Latest From NeoImmuneTech Inc.

Cellid IPO To Fund First-In-Class Cancer Immunotherapeutic Vaccines

After using government financial support to fund its early-stage clinical trials, Korean bioventure Cellid aims to further progress its first-in-class, cell-based cancer immunotherapeutic vaccines through an initial public offering in February.

South Korea Financing

Asia Deal Watch: Daiichi Sankyo Licenses Glycotope's Gatipotuzumab ADC

Daiichi Sankyo gains worldwide rights to an antibody-drug conjugate version of Glycotope’s gatipotuzumab for various cancers. Also, Tasly buys China rights to Mesoblast's CV candidates and India's Cipla grows in Africa.

Asia Pacific Deals

Deal Watch: Genentech Gets Down In The Dirt With Lodo Therapeutics

Genentech and Lodo will mine the soil microbiome to discover novel therapeutics. China’s Luye licenses commercial rights to AstraZeneca’s Seroquel franchise, while Sarepta picked up rights to gene therapy candidates from Myonexus, plus an option to acquire the company.
Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NeoImmuneTech Inc.
  • Senior Management
  • Se Hwan Yang, PhD, CEO
    Jaehan Park, Chief Strategy Officer
    Su Youn Nam, MD, PhD, CDO/CMO
    Samuel Zhang, PhD, Chief Bus. Officer
  • Contact Info
  • NeoImmuneTech Inc.
    Phone: (240) 801-9065
    2400 Research Blvd.
    Ste. 250
    Rockville, MD 20850
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register